Omega-3 Fatty-Acid Intake Improves Neurodevelopment in Preterm Girls
January 15, 2009 — Investigators observed an 80% reduction in the proportion of baby girls with significant mental delays when they had a diet rich in docosahexaenoic acid (DHA). These are the findings of a randomized controlled trial published in the January 14, 2009 issue of the Journal of the American Medical Association.
Although the researchers did not see statistically significant benefits in boys or babies born weighing less than 1250 g, they say that there appeared to be a reduction in the proportion of babies with significant mental delay in these groups with high-DHA treatment.
"We recommend increased DHA for all preterm infants born at less than 33 weeks' gestation," lead author Maria Makrides, PhD, from the Women's and Children's Hospital in Adelaide, Australia told Medscape Neurology & Neurosurgery.
We think that the level of DHA used in the treatment arm of our study should become the new gold standard for preterm infants.
"We think that the level of DHA used in the treatment arm of our study should become the new gold standard for preterm infants, whether it is supplied through breast milk or infant formula," Dr. Makrides said.
"It is important to note that we did not find negative effects of increasing the dietary DHA content. The high-DHA babies grew as well as those fed standard DHA, and we have confidence that the level of DHA used in the study — around 1% of the total dietary fat — was safe," she added.
0 comments:
Post a Comment